Gynecology cases performed successfully with FMX314

Following successful use of FMX314 in general surgery, the innovative platform for single-port laparoscopy has now been employed in several gynecologic procedures including tubal sterilization and ovarian cyst treatment with positive results, confirming the versatility of the platform for other surgical applications.
Read the full article

Fortimedix Surgical at SAGES 2016

Fortimedix Surgical is at SAGES again this year! Surgeons can visit us at booth #1122 on the exhibition floor to try out the FMX314 Surgical Platform and experience all of its features first-hand.
Read the full article

510(k) Submission with FDA for FMX314 Surgical Platform

Fortimedix Surgical announced today that it has submitted a premarket notification for the FMX314 Surgical Platform with the US Food and Drug Administration (FDA), under Section 510(k) of the Food, Drug and Cosmetic Act.
Read the full article

Note: FMX314 is the engineering code name for symphonX™ used during the pre-commercial phase.

 Download our Media Kit here. For media inquiries, please contact Marc van de Graaf via +1(858) 414 4989 or via our media(at)

Copyright © Fortimedix Surgical 2018. All rights reserved.


Stay updated about the latest developments and innovations from Fortimedix Surgical - subscribe to our newsletter via our subscription form.

By using our website you consent to all cookies in accordance with our Cookie Policy.